XXVIII Italian Society for the Study of Connective Tissues (SISC) Meeting, Pavia, Italy, 6–7 November 2008

REFERENCES

• Bonucci E. Biological Calcification. Normal and Pathological Processes in the Early Stage. Springer-Verlag, Berlin, Heidelberg 2007
   Google Scholar
• Glimcher M. J. Molecular biology of mineralized tissues with particular reference to bone. Rev. Modern Phys. 1959; 31: 359–393
   Google Scholar
• Glimcher M. J. The nature of the mineral component of bone and the mechanism of calcification. Metabolic Bone Disease and Clinically Related Disorders, L. V. Avioli, S. M. Krane. W.B. Saunders Company, Philadelphia 1990; 42–68
   Google Scholar
• Bonucci E. Fine structure of early cartilage calcification. J. Ultrastruct. Res. 1967; 20: 33–50
   PubMedGoogle Scholar
• Sela J., Schwartz Z., Swain L. D., Boyan B. D. The role of matrix vesicles in calcification. Calcification in Biological Systems, E. Bonucci. CRC Press, Boca Raton 1992; 73–10
   Google Scholar
• Bonucci E., Silvestrini G. Ultrastructure of the organic matrix of embryonic avian bone after en bloc reaction with various electron-dense ‘stains'. Acta anat. 1996; 156: 22–33
   PubMedGoogle Scholar
• Bonucci E., Reurink J. The fine structure of decalcified cartilage and bone: a comparison between decalcification procedures performed before and after embedding. Calcif. Tissue Res. 1978; 25: 179–190
   PubMedGoogle Scholar
• Shepard N. Role of proteoglycans in calcification. Calcification in Biological Systems, E. Bonucci. CRC Press, Boca Raton 1992; 41–5
   Google Scholar
• Bonucci E. Crystal ghosts and biological mineralization: fancy spectres in an old castle, or neglected structures worthy of belief?. J. Bone Miner. Metab. 2002; 20: 249–265
   PubMed Web of Science ®Google Scholar
• Bonucci E., Derenzini M., Marinozzi V. The organic-inorganic relationship in calcified mitochondria. J. Cell Biol. 1973; 59: 185–211
   PubMed Web of Science ®Google Scholar
• Bonucci E. Is there a calcification factor common to all calcifying matrices?. Scann. Electr. Microsc. 1987; 1: 1089–1102
   Google Scholar
• Glimcher M. J. Composition, structure, and organization of bone and other mineralized tissues and the mechanism of calcification. Handbook of Physiology: Endocrinology, R. O. Greep, E. B. Astwood. American Physiological Society, Washington 1976; 25–11
   Google Scholar
• Dong W., Warshawsky W. Failure to demonstrate a protein coat on enamel crystallites by morphological means. Archs Oral. Biol. 1995; 40: 321–330
   PubMed Web of Science ®Google Scholar
• Warshawsky W. Organization of crystals in enamel. Anat. Record 1989; 224: 242–262
   PubMedGoogle Scholar
• Aizenberg J., Hanson J., Ilan M., Leiserowitz L., Koetzle T. F., Addadi L., Weiner S. Morphogenesis of calcitic sponge spicules: a role for specialized proteins interacting with growing crystals. FASEB J. 1995; 9: 262–268
   PubMed Web of Science ®Google Scholar
• Berman A., Addadi L., Kvick Å., Leiserowitz L., Nelson M., Weiner S. Intercalation of sea urchin proteins in calcite: study of a crystalline composite material. Science 1990; 250: 664–667
   PubMed Web of Science ®Google Scholar
• Gotte L., Castellani A. A. La matrice intercellulare del tessuto connettivo. Riv. Istochim. Norm. Patol. 1971; 17: 239–282
   Google Scholar
• Bonucci E., Silvestrini G., Di-Grezia R. Histochemical properties of the “crystal ghosts” of calcifying epiphyseal cartilage. Connect.Tissue Res. 1989; 22: 43–50
   PubMedGoogle Scholar
• Bonucci E., Silvestrini G. Immunohistochemical investigation on the presence of chondroitin sulfate in calcification nodules of epiphyseal cartilage. Eur. J. Histochem. 1992; 36: 407–422
   PubMed Web of Science ®Google Scholar
• Kobayashi S. Acid mucopolysaccharides in calcified tissues. Int. Rev. Cytol. 1971; 30: 257–371
   PubMedGoogle Scholar
• Takagi M. Ultrastructural cytochemistry of cartilage proteoglycans and their relation to the calcification process. Ultrastructure of Skeletal Tissues, E. Bonucci, P. M. Motta. Kluwer Academic Publishers, Boston 1990; 111–12
   Google Scholar
• Sobel A. E. Local factors in the mechanism of calcification. Ann. NY Acad. Sci. 1955; 60: 713–731
   PubMed Web of Science ®Google Scholar
• Raspanti M., Viola M., Forlino A., Tenni R., Gruppi C., Tira M. E. Glycosaminoglycans show a specific periodic interaction with type I collagen fibrils. J. Struct. Biol. 2008; 164: 134–139
   PubMed Web of Science ®Google Scholar
• Sobel A. E., Burger M. Calcification XIV. Investigation of the role of chondroitin sulfate in the calcifying mechanism. Proc. Soc. Exper. Biol. Med. 1954; 87: 7–13
   PubMed Web of Science ®Google Scholar
• Albeck S., Aizenberg J., Addadi L., Weiner S. Interactions of various skeletal intracrystalline components with calcite crystals. J. Am. Chem. Soc. 1993; 115: 11691–11697
   Web of Science ®Google Scholar
• Weiner S., Traub W. Macromolecules in mollusc shells and their function in biomineralization. Phil. Trans. R. Soc. London 1984; 304B: 425–434
   Google Scholar
• Weiner S., Hood L. Soluble protein of the organic matrix of mollusk shells: a potential template for shell formation. Science 1975; 190: 987–989
   PubMed Web of Science ®Google Scholar
• Mann S. Molecular tectonics in biomineralization and biomimetic materials chemistry. Nature 1993; 365: 499–505
   Web of Science ®Google Scholar
• Pazzaglia U. E., Congiu T., Raspanti M., Ranchetti F., Quacci D. Anatomy of the intracortical canals of long bones: direct Scanning Electron Microscopy imaging in the rat femur. A scanning electron microscopy study. Clin. Orthopaedics Rel. Res. 2009, press
   PubMed Web of Science ®Google Scholar
• Aessopos A., Farmakis D., Loukopoulos D. Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta-thalassemia and the sickling syndromes. Blood 2002; 99: 30–35
   PubMed Web of Science ®Google Scholar
• Baccarani Contri M., Bacchelli B., Boraldi F., Quaglino D., Taparelli F., Francomano M. A., Seidenari S., Bettoli V., De Sanctis V., Pasquali Ronchetti I. Dermal alterations in inherited Pseudoxanthoma elasticum (PXE) and in PXE-like skin lesions of beta-thalassemic patients. J. Am. Acad. Dermatol. 2001; 44: 33–39
   PubMedGoogle Scholar
• Hamlin N., Beck K., Bacchelli B., Cianciulli P., Pasquali-Ronchetti I., Le Saux O. Acquired Pseudoxanthoma elasticum-like syndrome in beta-thalassaemia patients. Br. J. Haematol. 2003; 122: 852–854
   PubMed Web of Science ®Google Scholar
• Pasquali Ronchetti I., Garcia-Fernandez M. I., Boraldi F., Quaglino D., Gheduzzi D., Paolinelli DeVincenzi C., Tiozzo R., Bergamini S., Ceccarelli D., Moscatello U. The occurrence of oxidative stress in fibroblasts from patients with Pseudoxanthoma elasticum. Its role in the pathogenesis of clinical manifestations. J. Path. 2006; 208: 54–61
   PubMed Web of Science ®Google Scholar
• Livrea M. A., Tesoriere L., Pintaudi A. M., Calabrese A., Maggio A., Freisleben H. J., D'Arpa D., D'Anna R., Buongiorno A. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 1996; 88: 3608–3614
   PubMed Web of Science ®Google Scholar
• Gheduzzi D., Boraldi F., Annovi G., DeVincenzi C. P., Schurgers L. J., Vermeer C., Quaglino D., Pasquali Ronchetti I. Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients. Lab. Invest. 2007; 87: 998–1008
   PubMed Web of Science ®Google Scholar
• Borst P., van de Wetering K., Schlingemann R. Does the absence of ABCC6 (multidrug resistance protein 6) in patients with Pseudoxanthoma elasticum prevent the liver from providing sufficient vitamin K to the periphery?. Cell Cycle 2008; 7: 1575–1579
   PubMed Web of Science ®Google Scholar
• Scott J. E. Supramolecular organisation of extracellular matrix glycosaminoglycans, in vitro and in the tissues. FASEB J. 1992; 6: 2639–2645
   PubMed Web of Science ®Google Scholar
• Scott J. E. Proteodermatan and proteokeratan sulfate (decorin, lumican-fibromodulin) proteins are horseshoe shaped. Implications for their interactions with collagen. Biochemistry 1996; 35: 8795–8799
   PubMed Web of Science ®Google Scholar
• Scott P. G., McEwan P. A., Dodd C. M., et al. Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglyca. PNAS 2004; 101: 15633–15638
   PubMed Web of Science ®Google Scholar
• Kalamajskim S., Aspberg A., Oldberg A. The decorin sequence SYIRIADTNIT binds collagen type 1. J. Biol. Chem. 2007; 282: 16062–16067
   PubMed Web of Science ®Google Scholar
• Orgel J.P.R.O., Irving T. C., Miller A., Wess T. J. Microfibrillar structure of type 1 collagen in situ. PNAS 2006; 103: 9001–9005
   PubMed Web of Science ®Google Scholar
• Cattaruzza S., Perris R. Approaching the proteoglycome: molecular interactions of proteoglycans and their functional output. Macromol. Biosci. 2006; 6: 667–680
   PubMed Web of Science ®Google Scholar
• Casini P., Ori M., Avenoso A., D'Ascola A., Traina P., Mattina W., Perris R., Campo G. M., Calatroni A., Nardi I., Campo S. Identification and gene expression of versican during early development o. Xenopus. Int. J. Dev. Biol. 2008; 52: 993–918
   PubMed Web of Science ®Google Scholar
• Finkel T. Radical medicine: treating ageing to cure disease. Nat. Rev. Mol. Cell. Biol. 2005; 6: 971–976
   PubMed Web of Science ®Google Scholar
• Braam B., Langelaar-Makkinje M., Verkleij A., Bluyssen H., Verrips T., Koomans H. A., Joles J. A., Post J. A. Anti-oxidant sensitivity of donor age-related gene expression in cultured fibroblasts. Eur. J. Pharmacol. 2006; 542: 154–161
   PubMed Web of Science ®Google Scholar
• Cristofalo V. J., Volker C., Francis M. K., Tresini M. Age-dependent modifications of gene expression in human fibroblasts. Crit. Rev. Eukaryot. Gene Expr. 1998; 8: 43–80
   PubMed Web of Science ®Google Scholar
• Robert L., Labat-Robert J. Aging of connective tissues: from genetic to epigenetic mechanisms. Biogerontology 2003; 1: 123–131
   Google Scholar
• Krtolica A., Campisi J. Integrating epithelial cancer, aging stroma and cellular senescence. Adv. Gerontol. 2003; 11: 109–116
   PubMedGoogle Scholar
• Boraldi F., Bini L., Liberatori S., Armini A., Pallini V., Tiozzo R., Pasquali-Ronchetti I., Quaglino D. Proteome analysis of dermal fibroblasts cultured in vitro from human healthy subjects of different ages. Proteomics 2003; 3: 917–929
   PubMed Web of Science ®Google Scholar
• Krøll J. Molecular chaperones and the epigenetics of longevity and cancer resistance. Ann. NY Acad. Sci. 2007; 1100: 75–83
   PubMed Web of Science ®Google Scholar
• Robert L., Robert A. M., Fülöp T. Rapid increase in human life expectancy: will it soon be limited by the aging of elastin?. Biogerontology 2008; 9: 119–133
   PubMed Web of Science ®Google Scholar
• Tlsty T. D., Coussens L. M. Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 2006; 1: 119–150
   PubMed Web of Science ®Google Scholar
• Pucci-Minafra I., Albanese N. N., Di Cara G., Minafra L., Marabeti M. M., Cancemi P. Breast cancer cells exhibit selective modulation induced by different collagen substrates. Connect. Tissue Res. 2008; 49: 252–256
   PubMed Web of Science ®Google Scholar
• Albini A. Tumor microenvironment, a dangerous society leading to cancer metastasis. From mechanisms to therapy and prevention. Cancer Metastasis Rev. 2008; 27: 3–4
   PubMed Web of Science ®Google Scholar
• Prochownik E. V. c-Myc: linking transformation and genomic instability. Curr. Mol. Med. 2008; 8: 446–458
   PubMed Web of Science ®Google Scholar
• La Rocca G., Pucci-Minafra I., Marrazzo A., Taormina P., Minafra S. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br. J. Cancer 2004; 90: 1414–1421
   PubMed Web of Science ®Google Scholar
• Rydlova M., Holubec L., Jr, Ludvikova M., Jr, Kalfert D., Franekova J., Povysil C., Ludvikova M. Biological activity and clinical implications of the matrix metalloproteinases. Anticancer Res. 2008; 28: 1389–1397
   PubMed Web of Science ®Google Scholar
• Spicer A. P., Tien J. L., Joo A., Bowling R. A. Investigation of hyaluronan function in the mouse through targeted mutagenesis. Glycoconj. J. 2002; 19: 341–345
   PubMed Web of Science ®Google Scholar
• Li Y., Li L., Brown T. J., Heldin P. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Intl. J. Cancer 2007; 120: 2557–2567
   PubMed Web of Science ®Google Scholar
• Pickart C. M., Fushman D. Polyubiquitin chains: polymeric protein signals. Curr. Opin. Chem. Bio. 2004; 18: 610–616
   Google Scholar
• Quinlan G. J., Martin G. S., Evans T. W. Albumin: biochemical properties and therapeutic potential. Hepatology 2005; 41: 1211–1219
   PubMed Web of Science ®Google Scholar
• Carballal S., Alvarez B., Turell L., Botti H., Freeman B. A., Radi R. Sulfenic acid in human serum albumin. Amino Acids 2007; 32: 543–551
   PubMed Web of Science ®Google Scholar
• Klatt P., Lamas S. Regulation of protein function by S glutathiolation in response to oxidative and nitrosative stress. Eur. J. Biochem. 2000; 267: 4928–4944
   PubMedGoogle Scholar
• Lepedda A. J., Cigliano A., Cherchi G. M., Spirito R., Maggioni M., Carta F., Turrini F., Edelstein C., Scanu A. M., Formato M. A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis 2009, in press
   PubMed Web of Science ®Google Scholar
• Raspanti M., Viola M., Sonaggere M., Tira M. E., Tenni R. Collagen fibril structure is affected by collagen concentration and decorin. Biomacromolecules 2007; 8: 2087–2091
   PubMed Web of Science ®Google Scholar
• Raspanti M., Viola M., Forlino A., Tenni R., Gruppi C., Tira M. E. Glycosaminoglycans show a specific periodic interaction with type I collagen fibrils. J. Struct.Biol. 2008; 164: 134–139
   PubMed Web of Science ®Google Scholar
• Liao J., Vesely I. Skewness angle of interfibrillar proteoglycans increases with applied load on mitral valve chordae tendineae. J.Biomech. 2007; 40: 390–398
   PubMed Web of Science ®Google Scholar
• Liu X., Yeh M.-L., Lewis J. L., Luo Z.-P. Direct measurement of the rupture force of single pair of decorin interactions. Biochem.Bioph.Res.Co. 2005; 338: 1342–1345
   PubMed Web of Science ®Google Scholar
• Osborne C. S., Barbenel J. C., Smith D., Savakis M., Grant M. H. Investigation into the tensile properties of collagen/chondritin-6-sulphate gels: the effect of crosslinking agents and diamines. Med.Biol.Eng.Comput. 1998; 36: 129–134
   PubMed Web of Science ®Google Scholar
• Byers P. H., Cole W. G. Osteogenesis Imperfecta. Connective Tissue and Heritable Disorders 2nd, P. M. Royce, B. Steinmann. Wiley-Liss, New York 2002; 385–430
   Google Scholar
• Marini J. C., Forlino A., Cabral W. A., Barnes A. M., San Antonio J. D., Milgrom S., Hyland J. C., Körkkö J., Prockop D. J., De Paepe A., Coucke P., Symoens S., Glorieux F. H., Roughley P. J., Lund A. M., Kuurila Svahn K., Hartikka H., Cohn D. H., Krakow D., Mottes M., Schwarze U., Chen D., Yang K., Kuslich C., Troendle J., Dalgleish R., Byers P. H. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum. Mutat. 2007; 28: 209–221
   PubMed Web of Science ®Google Scholar
• Morello R., Bertin T. K., Chen Y., Hicks J., Tonachini L., Monticone M., Castagnola P., Rauch F., Glorieux F. H., Vranka J., Bächinger H. P., Pace J. M., Schwarze U., Byers P. H., Weis M., Fernandes R. J., Eyre D. R., Yao Z., Boyce B. F., Lee B. CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell. 2006; 127: 291–304
   PubMed Web of Science ®Google Scholar
• Barnes A. M., Chang W., Morello R., Cabral W. A., Weis M., Eyre D. R., Leikin S., Makareeva E., Kuznetsova N., Uveges T. E., Ashok A., Flor A. W., Mulvihill J. J., Wilson P. L., Sundaram U. T., Lee B., Marini J. C. Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N. Engl. J. Med. 2006; 355: 2757–2764
   PubMed Web of Science ®Google Scholar
• Cabral W. A., Chang W., Barnes A. M., Weis M., Scott M. A., Leikin S., Makareeva E., Kuznetsova N. V., Rosenbaum K. N., Tifft C. J., Bulas D. I., Kozma C., Smith P. A., Eyre D. R., Marini J. C. Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder re-sembling lethal/severe osteogenesis imperfecta. Nat. Genet. 2007; 39: 359–365
   PubMed Web of Science ®Google Scholar
• Marini J. C., Cabral W. A., Barnes A. M., Chang W. Components of the collagen prolyl 3-hydroxylation complex are crucial for normal bone development. Cell Cycle 2007; 6: 1675–1681
   PubMed Web of Science ®Google Scholar
• Baldridge D., Schwarze U., Morello R., Lennington J., Bertin T. K., Pace J. M., Pepin M. G., Weis M., Eyre D. R., Walsh J., Lambert D., Green A., Robinson H., Michelson M., Houge G., Lindman C., Martin J., Ward J., Lemyre E., Mitchell J. J., Krakow D., Rimoin D. L., Cohn D. H., Byers P. H., Lee B. CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum. Mutat. 2008; 19: 19
   Google Scholar
• Sillence D. O., Rimoin D. L. Classification of osteogenesis imperfect. Lancet. 1978; 1: 1041–1042
   PubMed Web of Science ®Google Scholar
• Forlino A., Porter F. D., Lee E. J., Westphal H., Marini J. C. Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice. J. Biol. Chem. 1999; 274: 37923–37931
   PubMed Web of Science ®Google Scholar
• Kozloff K. M., Carden A., Bergwitz C., Forlino A., Uveges T. E., Morris M. D., Marini J. C., Goldstein S. A. Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength. J. Bone Miner. Res. 2004; 19: 614–622
   PubMed Web of Science ®Google Scholar
• Kuznetsova N. V., Forlino A., Cabral W. A., Marini J. C., Leikin S. Structure, stability and interactions of type I collagen with GLY349-CYS substitution in alpha 1(I) chain in a murine Osteogenesis Imperfecta model. Matrix Biol. 2004; 23: 101–112
   PubMed Web of Science ®Google Scholar
• Uveges T. E., Collin-Osdoby P., Cabral W. A., Ledgard F., Goldberg L., Bergwitz C., Forlino A., Osdoby P., Gronowicz G. A., Marini J. C. Cellular mechanism of decreased bone in Brtl mouse model of OI: Imbalance of decreased osteoblast function and increased Osteoclasts and their precursors. J Bone Miner Res. 2008; 6: 6
   Google Scholar
• Oyadomari S., Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 2004; 11: 381–389
   PubMed Web of Science ®Google Scholar
• Behnam K., Murray S. S., Whitelegge J. P., Brochmann E. J. Identification of the molecular chaperone alpha B-crystallin in demineralized bone powder and osteoblast-like cells. J. Orthop. Res. 2002; 20: 1190–1196
   PubMed Web of Science ®Google Scholar
• Horwitz E. M., Gordon P. L., Koo W. K., Marx J. C., Neel M. D., McNall R. Y., Muul L., Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc. Natl. Acad. Sci. USA. 2002; 99: 8932–8937
   PubMed Web of Science ®Google Scholar
• Horwitz E. M., Prockop D. J., Fitzpatrick L. A., Koo W. W., Gordon P. L., Neel M., Sussman M., Orchard P., Marx J. C., Pyeritz R. E., Brenner M. K. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 1999; 5: 309–313
   PubMed Web of Science ®Google Scholar
• Le Blanc K., Gotherstrom C., Ringden O., Hassan M., McMahon R., Horwitz E., Anneren G., Axelsson O., Nunn J., Ewald U., Nordén-Lindeberg S., Jansson M., Dalton A., Aström E., Westgren M. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation. 2005; 79: 1607–1614
   PubMed Web of Science ®Google Scholar
• Chipman S. D., Sweet H. O., McBride D. J., Jr. Davisson M. T., Marks S. C., Jr. Shuldiner A. R., Wenstrup R. J., Rowe D. W., Shapiro J. R. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc. Natl. Acad. Sci. USA. 1993; 90: 1701–1705
   PubMed Web of Science ®Google Scholar
• Li F., Wang X., Niyibizi C. Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation. Stem Cells 2007; 25: 3183–3193
   PubMed Web of Science ®Google Scholar
• Guillot P. V., Abass O., Bassett J. H., Shefelbine S. J., Bou-Gharios G., Chan J., Kurata H., Williams G. R., Polak J., Fisk N. M. Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 2008; 111: 1717–1725
   PubMed Web of Science ®Google Scholar
• Hästbacka J., De la Chapelle A., Mahtani M. M., Clines G., Reeve-Daly M. P., Daly M., Hamilton B. A., Kusumi K., Trivedi B., Weaver A., Coloma A., Lovett M., Buckle A. R., Kaitila I., Lander E. S. The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell 1994; 78: 1073–1087
   PubMed Web of Science ®Google Scholar
• Forlino A., Rossi A. A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype. Hum. Mol. Gen. 2005; 14: 859–871
   PubMed Web of Science ®Google Scholar
• Plomp A. S., Florijn R. J., Ten Brink J., Castle B., Kingston H., Martín-Santiago A., Gorgels T. G., de Jong P. T., Bergen A. A. ABCC6 mutations in pseudoxanthoma elasticum: an update including eight novel ones. Mol. Vis. 2008; 14: 118–124
   PubMed Web of Science ®Google Scholar
• Vanakker O. M., Leroy B. P., Coucke P., Bercovitch L. G., Uitto J., Viljoen D., Terry S. F., Van Acker P., Matthys D., Loeys B., DePaepe A. Novel clinico-molecular insights in pseudoxanthoma elasticum provide an efficient molecular screening method and a comprehensive diagnostic flowchart. Hum. Mutat. 2008; 29: 205
   PubMedGoogle Scholar
• Pfendner E. G., Vanakker O. M., Terry S. F., Vourthis S., McAndrew P. E., McClain M. R., Fratta S., Marais A. S., Hariri S., Coucke P. J., Ramsay M., Viljoen D., Terry P. F., De Paepe A., Uitto J., Bercovitch L. G. Mutation detection in the ABCC6 gene and genotype-phenotype analysis in a large international case series affected by pseudoxanthoma elasticum. J. Med. Genet. 2007; 44: 621–628
   PubMed Web of Science ®Google Scholar
• Garcia-Fernandez M. I., Gheduzzi D., Boraldi F., Paolinelli C. D., Sanchez P., Valdivielso P., Morilla M. J., Quaglino D., Guerra D., Casolari S., Bercovitch L., Pasquali-Ronchetti I. Parameters of oxidative stress are present in the circulation of PXE patients. Biochim. Biophys. Acta. 2008; 1782: 474–481
   PubMed Web of Science ®Google Scholar
• Gheduzzi D., Guidetti R., Anzivino C., Tarugi P., Di Leo E., Quaglino D., Pasquali Ronchetti I. ABCC6 mutations in Italian families affected by Pseudoxanthoma Elasticum (PXE). Hum. Mutat. 2004; 24: 438–439
   PubMedGoogle Scholar
• Bacchelli B., Quaglino D., Gheduzzi D., Taparelli F., Boraldi F., Trolli B., Le Saux O., Boyd C. D., Ronchetti I. Identification of heterozygote carriers in families with a recessive form of pseudoxanthoma elasticum (PXE). Mod.Pathol. 1999; 12: 1112–1123
   PubMed Web of Science ®Google Scholar
• Martin L., Maître F., Bonicel P., Daudon P., Verny C., Bonneau D., LeSaux O., Chassaing N. Heterozygosity for a single mutation in the ABCC6 gene may closely mimic PXE: consequences of this phenotype overlap for the definition of PXE. Arch. Dermatol. 2008; 144: 301–306
   PubMed Web of Science ®Google Scholar
• Li Q., Grange D. K., Armstrong N. L., Whelan A. J., Hurley M. Y., Rishavy M. A., Hallgren K. W., Berkner K. L., Schurgers L. J., Jiang Q., Uitto J. Mutations in the GGCX and ABCC6 Genes in a family with Pseudoxanthoma elasticum-like phenotypes. J. Invest. Dermatol 2008, doi: 10.1038/jid.2008.271
   Web of Science ®Google Scholar
• Gheduzzi D., Sammarco R., Quaglino D., Terry S., Bercovitch L., Pasquali Ronchetti I. Extracutaneous connective tissue alterations in Pseudoxanthoma elasticum. Ultrastruct. Pathol. 2003; 27: 1–11
   PubMedGoogle Scholar
• Le Saux O., Urban Z., Tschuch C., Csiszar K., Bacchelli B., Quaglino D., Pasquali Ronchetti I., Pope M., Richards A., Terry S., Bercovitch L., De Paepe A., Boyd C. Mutations in a gene encoding an ABC transporter cause Pseudoxanthoma elasticum. Nat. Genet. 2000; 25: 223–227
   PubMed Web of Science ®Google Scholar
• Garcia-Fernandez M. I., Gheduzzi D., Boraldi F., Paolinelli C. D., Sanchez P., Valdivielso P., Morilla M. J., Quaglino D., Guerra D., Casolari S., Bercovitch L., Pasquali-Ronchetti I. Parameters of oxidative stress are present in the circulation of PXE patients. Biochim. Biophys. Acta 2008; 1782: 474–481
   PubMed Web of Science ®Google Scholar
• Pasquali Ronchetti I., Garcia-Fernandez M. I., Boraldi F., Quaglino D., Gheduzzi D., Paolinelli DeVincenzi C., Tiozzo R., Bergamini S., Ceccarelli D., Muscatello U. The occurrence of oxidative stress in fibroblasts from patients with Pseudoxanthoma elasticum. Its role in the pathogenesis of clinical manifestations. J. Pathol. 2006; 207: 54–61
   Google Scholar
• Jofre-Monseny L., Minihane A. M., Rimbach G. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol. Nutr. Food Res. 2008; 52: 131–145
   PubMed Web of Science ®Google Scholar
• Kohlmeier M., Salomon A., Saupe J., Shearer M. J. Transport of vitamin K to bone in humans. J. Nutr. 1996; 126: 11925–11965
   Google Scholar
• Saupe J., Shearer M. J., Kohlmeier M. Phylloquinone transport and its influence on gamma-carboxyglutamate residues of osteocalcin in patients on maintenance hemodialysis. Am. J. Clin. Nutr. 1993; 58: 204–208
   PubMed Web of Science ®Google Scholar
• Gheduzzi D., Boraldi F., Annovi G., Paolinelli DeVincenzi C., Schurgers L., Vermeer C., Quaglino D., Pasquali Ronchetti I. Matrix Gla protein is involved in elastic fiber calcification in the dermis of Pseudoxanthoma elasticum patients. Lab. Invest. 2007; 87: 998–1008
   PubMed Web of Science ®Google Scholar
• Schurgers L. J., Dissel P. E., Spronk H. M., Soute B. A., Dhore C. R., Cleutjens J. P., Vermeer C. Role of vitamin K and vitamin K-dependent proteins in vascular calcification. Z Kardiol. 2001; 90(suppl 3)57–63
   PubMedGoogle Scholar
• Peroutka S. J., Dreon D. M. The value of genotyping for apolipoprotein E alleles in relation to vitamin E supplementation. Eur. J. Pharmacol. 2000; 410: 161–163
   PubMed Web of Science ®Google Scholar
• Fassina L., Saino E., Visai L., Silvani G., Cusella De Angelis M. G., Mazzini G., Benazzo F., Magenes G. Electromagnetic enhancement of a culture of human SAOS-2 osteoblasts seeded onto titanium fiber-mesh scaffolds. J. Biomed. Mater. Res. A. 2008; 87: 750–759
   PubMedGoogle Scholar
• Hutmacher D. W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2001; 21: 2529–2543
   Web of Science ®Google Scholar
• Maquet V., Boccaccini A. R., Pravata L., Notingher I., Jérôme R. Porous poly(α -hydroxyacid)/bioglass composite scaffolds for bone tissue engineering: preparation and in vitro characteristics. Biomaterials 2004; 25: 4185–4194
   PubMed Web of Science ®Google Scholar
• Chen Q. Z., Beccaccini A. R. Poly(D,L-lactic acid) coated 45S5 Bioglass®-based scaffolds:processing and characterization. J. Biomed. Mater. Res. 2006; 77(A)445–457
   Google Scholar
• Fassina L., Visai L., Benazzo F., Benedetti L., Calligaro A., De Angelis M. G., Farina A., Maliardi V., Magenes G. Effects of electromagnetic stimulation on calcified matrix production by SAOS-2 cells over a polyurethane porous scaffold. Tissue Eng. 2006; 12: 1985–1999
   PubMedGoogle Scholar
• De Ugarte D. A., et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cell Tissues Organs 2003; 174: 101–109
   PubMed Web of Science ®Google Scholar
• Cowan C. M., et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat. Biotechnol. 2004; 22: 560–567
   PubMed Web of Science ®Google Scholar
• Strem B. M., et al. Multipotential differentiation of adipose tissue-derived stem cells. Kejo. J. Med. 2005; 54: 132–141
   PubMed Web of Science ®Google Scholar
• Puleo D., et al. Current challenger in cell-biomaterial interaction. Preface Biomater. 1999; 20: 2201
   Google Scholar
• Albini A. Tumor microenvironment, a dangerous society leading to cancer metastasis. From mechanisms to therapy and prevention. Cancer Metastasis Rev. 2008; 27: 3–4
   PubMed Web of Science ®Google Scholar
• Dell'Aica I., Caniato R., Biggin S., Garbisa S. Matrix proteases, green tea, and St. John's wort: Biomedical research catches up with folk medicine. Clinica Chimica Acta 2007; 381: 69–77
   PubMed Web of Science ®Google Scholar
• Albini A., Sporn M. B. The tumor microenvironment as a target for chemoprevention. Nat. Rev. Cancer 2007; 7(2)139–147
   PubMed Web of Science ®Google Scholar
• Fassina G., Venè R., Morini M., Minghelli S., Benelli R., Noonan D. M., Albini A. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clinical Cancer Res. 2004; 10: 4865–4873
   PubMed Web of Science ®Google Scholar
• Pezzato E., Donà M., Sartor L., Dell'Aica I., Benelli R., Albini A., Garbisa S. Proteinase-3 directly activates MMP-2 and degrades gelatin and matrigel; differential inhibition by (-) epigallocatechin-3-gallate. J. Leukoc. Biol. 2003; 74: 88–94
   PubMed Web of Science ®Google Scholar
• Bachmeier B. E., Nerlich A. G., Iancu C. M., Cilli M., Schleicher E., Venè R., Dell'Eva R., Jochum M., Albini A., Pfeffer U. The chemopreventive polyphenol curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell. Physiol. Biochem. 2007; 19: 137–152
   PubMed Web of Science ®Google Scholar
• Dell'Aica I., Niero R., Piazza F., Cabrelle A., Sartor L., Colalto C., Brunetta E., Lorusso G., Benelli R., Albini A., Calabrese F., Agostini C., Grabisa S. Hyperphorin blocks neutrophil activation of matrix metalloproteinase-2, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis. J. Pharm. Exper. Ther. 2007; 321: 492–500
   PubMed Web of Science ®Google Scholar
• Goldschmidt M. H., Dunstan R. W., Stannard A. A., von Tscharner C., Walder E. J., Yager J. A. World Health Organization International Histological Classification of Spontaneous Animal Tumours—second series, vol. III. Epithelial and Melanocytic Tumours of the Skin of Domestic Animals 1998; 22–23
   Google Scholar
• Abramo F., Pratesi F., Cantile C., Sozzi S., Poli A. Survey of canine and feline follicular tumours and tumour-like lesions in central Italy. J. Small Animal Pract. 1999; 40: 479–481
   PubMed Web of Science ®Google Scholar
• Millar S. E. Molecular mechanisms regulating hair follicle development. J. Invest. Dermatol. 2002; 18: 216–225
   Google Scholar
• Losa G. A., Alini M. Sulfated proteoglycans in the extracellular matrix of human breast tissues with infiltrating carcinoma. Int. J. Cancer 1993; 54: 552–557
   PubMed Web of Science ®Google Scholar
• Russo J., Linch H., Russo J. H. Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J. 2001; 7: 278–291
   PubMedGoogle Scholar
• Bissel M. J., Hall H. G. Form and function in the mammary gland: the role of the extracellular matrix. The Mammary Gland: Development, Regulation and Function, M. Nevell, C. Daniel. Plenum Publishing Corp, New York 1987; 97–146
   Google Scholar
• Losa G. A., Nonnenmacher T. F. Self-similarity and fractal irregularity in pathologic tissues. Modern Pathol. 1996; 9: 174–182
   PubMed Web of Science ®Google Scholar
• Moscatello D. K., Santa M., Mann D. M., McQuillan D. J., Wong A. J., Iozzo R. V. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J. Clin. Invest. 1998; 101: 406–412
   PubMed Web of Science ®Google Scholar
• Iozzo. R. V., Moscatello D. K., McQuillan D. J., Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem. 1999; 274: 4489–4492
   PubMed Web of Science ®Google Scholar
• Pucci-Minafra I., Cancemi P., Di Cara G., Minafra L., Feo S., Forlino A., Tira M. E., Tenni R., Martini D., Ruggeri A., Minafra S. Decorin transfection induces proteomic and phenotypic modulation in breast cancer cells 8701-BC. Connect Tissue Res. 2008; 49: 30–41
   PubMed Web of Science ®Google Scholar
• Pucci-Minafra I., Cancemi P., Fontana S., Minafra L., Feo S., Becchi M., Freyria A. M., Minafra S. Expanding the protein catalogue in the proteome reference map of human breast cancer cells. Proteomics 2006; 6: 2609–2625
   PubMed Web of Science ®Google Scholar
• Salama I., Malone P. S., Mihaimeed F., Jones J. L. A review of the S100 proteins in cancer. Eur. J. Surg. Onco. 2008; 34: 357–364
   PubMed Web of Science ®Google Scholar
• Pucci-Minafra I., Fontana S., Cancemi P., Basificò L., Caricato S., Minafra S. A contribution to breast cancer cell proteomics: detection of new sequences. Proteomics 2002; 2: 919–927
   PubMed Web of Science ®Google Scholar
• Pucci-Minafra I., Cancemi P., Fontana S., Minafra L., Feo S., Becchi M., Freyria A. M., Minafra S. Expanding the protein catalogue in the proteome reference map of human breast cancer cells. Proteomics 2006; 6: 2609–2625
   PubMed Web of Science ®Google Scholar
• Pucci-Minafra I., Cancemi P., Marabeti M. R., Albanese N. N., Di Cara G., Taormina P., Marrazzo A. Proteomic profiling of 13 paired ductal infiltrating breast carcinomas and non-tumoral adjacent counterparts. Proteomics Clini. Appl. 2007; 1: 118–129
   PubMed Web of Science ®Google Scholar
• Pucci-Minafra I., Cancemi P., Albanese N. N., Di Cara G., Marabeti M. R., Marrazzo A., Minafra S. New protein clustering of breast cancer tissue proteomics using actin content as a cellularity indicator. J. Proteome Res. 2008; 7: 1412–1418
   PubMed Web of Science ®Google Scholar
• Halliwell B. Oxidative stress and cancer: have we moved forward?. Biochem. J. 2007; 401: 1–11
   PubMed Web of Science ®Google Scholar
• Manach C., Williamson G., Morand C., Scalbert A., Rémeséy C. Bioavailability and bioefficacy of poliphenols in humans. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005; 81: 230S–242S
   PubMed Web of Science ®Google Scholar
• Murphy M. P., Smith R. A. Targeting antioxidants to mitochondria by conjugation to lipophilic cation. Annu. Rev. Pharmacol. Toxicol. 2007; 47: 629–656
   PubMed Web of Science ®Google Scholar
• Biasutto L., Mattarei A., Marotta E., Bradaschia A., Sassi N., Garbisa G., Zoratti M., Paradisi C. Development of mitochondria-targeted derivatives of resveratrol. Bioorg. Med. Chem. Lett. 2008; 18: 5594–5597
   PubMed Web of Science ®Google Scholar
• Schempp C. M., Kirkin V., Simon-Haarhau B., Kersten A., Kiss J., Termeer C. C., Gilb B., Kaufmann T., Borner C., Sleeman J. P., Simon J. C. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis. Oncogene 2002; 21: 1242–1250
   PubMed Web of Science ®Google Scholar
• Quiney C., Billard C., Mirshahi P., Fourneron J. D., Kolb J. P. Hyperforin inhibits MMP-9 secretion by B-CLL cells and microtubule formation by endothelial cells. Leukemia 2006; 20: 583–589
   PubMed Web of Science ®Google Scholar
• Donà M., Dell'Aica I., Pezzato E., Sartor L., Calabrese F., Della Barbera M., Donella Deana A., Appendino G., Borsarini A., Caniato R., Garbisa S. Hyperforin inhibits cancer invasion and metastasis. Cancer Res. 2004; 64: 6225–6232
   PubMed Web of Science ®Google Scholar
• Trentin L., Miorin M., Facco M., Basso I., Carraio S., Cabrelle A., Maschio N., Bortoli M., Bigotto G., Piazza F., Adami F., Zimbello R., Agostani C., Semenzato G. Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity. Br. J. Haematol. 2007; 138: 594–602
   PubMed Web of Science ®Google Scholar
• Alsayed Y., Ngo H., Runnels J., Leleu X., Singha U. K., Pitsillides C. M., Spencer J. A., Kimlinger T., Ghobrial J. M., Jia X., Lu G., Timm M., Kumar A., Côté D., Veilleux I., Hedin K. E., Roodman G. D., Witzig T. E., Kung A. L., Hideshima T., Anderson K. C., Lin C. P., Ghobrial I. M. Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood 2007; 109: 2708–2717
   PubMed Web of Science ®Google Scholar
• Franchi M., Fini M., Quaranta M., De Pasquale V., Raspanti M., Giavaresi G., Ottani V., Ruggeri A. Crimp morphology in relaxed and stretched rat Achilles tendon. J. Anat. 2007; 210: 1–7
   PubMed Web of Science ®Google Scholar
• Rumian A. P., Wallace A. L., Birch H. L. Tendons and ligaments are anatomically distinct but overlap in molecular and morphological features—A comparative study in an ovine model. J. Orthop. Res. 2007; 25: 458–464
   PubMed Web of Science ®Google Scholar
• Fung D.T. C., Ng G.Y. F., Leung M.C. P., Tay D.K.C. Investigation of the collagen fibril distribution in the medial collateral ligament in rat knee model. Connect. Tissue Res. 2003; 44: 2–11
   PubMed Web of Science ®Google Scholar
• Campo G. M., D'Ascola A., Avenoso A., Campo S., Ferlazzo A. M., Micali C., Zanghì L., Calatroni A. Glycosaminoglycans reduce oxidative damage induced by copper (Cu+2), iron (Fe+2) and hydrogen peroxide (H2O2) in human fibroblast cultures. Glycoconj. J. 2004; 20: 133–141
   PubMed Web of Science ®Google Scholar
• Campo G. M., Avenoso A., Campo S., D'Ascola A., Traina P., Samà D., Calatroni A. The antioxidant effect exerted by TGF-1beta-stimulated hyaluronan production, reduced NF-kB activation and apoptosis in human fibroblasts exposed to FeSO4plus ascorbate. Mol. Cell Biochem. 2008; 311: 167–177
   PubMed Web of Science ®Google Scholar
• Jomphe C., Gabriac M., Hale T. M., Héroux L., Troudeau L. E., Deblois D., Montell E., Vergés J., Du Souich P. Chondroitin sulphate inhibits the nuclear traslocation of nuclear factor-kappaB in interleukin-1 beta-stimulated chondrocytes. Basic Clin. Pharmacol. Toxicol. 2008; 102: 59–65
   PubMed Web of Science ®Google Scholar
• Brentano F., Kyburz D., Schorr O., Gay R., Gay S. The role of Toll-like receptor signalling in the pathogenesis of arthritis. Celll Immunol. 2005; 233: 90–96
   PubMed Web of Science ®Google Scholar
• Termeer C., Benedix F., Sieeman J., Fieber C., Voith U., Ahrens T., Miyake K., Freudenberg F., Galanos C., Simon J. C. Oligosaccharides of Hyaluronan activate dendridic cells via toll-like receptor4. J. Exp. Med. 2002; 195: 99–111
   PubMed Web of Science ®Google Scholar
• Johnson G. B., Brunn G. J., Kodaira Y., Platt J. L. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol. 2002; 168: 5233–5239
   PubMed Web of Science ®Google Scholar
• Chang Y., Auradé F., Larbret F., Zhang Y., Le Couedic J. P., Momeux L., Larghero J., Bertoglio J., Louache F., Cramer E., Vainchenker W., Debili N. Proplatelet formation is regulated by the Rho/ROCK pathway. Blood 2007; 109: 4229–4236
   PubMedGoogle Scholar
• Balduini A., Pallotta I., Malara A., Lova P., Pecci A., Viarengo G., Balduini C. L., Torti M. Adhesive receptors, extracellular proteins, and myosin IIA orchestrate proplatelet formation by human megakaryocytes. J. Thromb. Haemost 2008; 6: 1900–1907
   PubMed Web of Science ®Google Scholar
• Lusis A. J. Atherosclerosis. Nature 2000; 407: 233–241
   PubMed Web of Science ®Google Scholar
• Doran A. C., Meller N., McNamara C. A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2008; 28: 812–819
   PubMed Web of Science ®Google Scholar
• Vigetti D., Viola M., Karousou E., Rizzi M., Moretto P., Genasetti A., Clerici M., Hascall V. C., De Luca G., Passi A. Hyaluronan-CD44-ERK1/2 regulate human aortic smooth muscle cell motility during aging. J. Biol. Chem. 2008; 283: 4448–4458
   PubMed Web of Science ®Google Scholar
• Vigetti D., Moretto P., Viola M., Genasetti A., Rizzi M., Karousou E., Pallotti F., De Luca G., Passi A. Matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro aging. FASEB J. 2006; 20: 1118–1130
   PubMed Web of Science ®Google Scholar
• Toole B. P., Wight T. N., Tammi M. I. Hyaluronan-cell interactions in cancer and vascular disease. J. Biol. Chem. 2002; 277: 4593–4596
   PubMed Web of Science ®Google Scholar
• Vigetti D., Viola M., Karousou E., Rizzi M., Moretto P., Gennasetti A., Clerici M., Hascall V. C., De Luca G., Passi A. Hyaluronan-CD44-ERK1/2 regulate human aortic smooth muscle cell motility during aging. J. Biol. Chem. 2008; 283: 4448–4458
   PubMed Web of Science ®Google Scholar
• Vigetti D., Ori M., Viola M., Gennasetti A., Karousou E., Rizzi M., Pallotti F., Nardi I., Hascall V. C., De Luca G., Passi A. Molecular cloning and characterization of UDP-glucose dehydrogenase from the amphibian Xenopus laevis and its involvement in hyaluronan synthesis. J. Biol. Chem. 2006; 281: 8254–8263
   PubMed Web of Science ®Google Scholar
• Igata M., Motoshima H., Tsuruzoe K., Kojima K., Matsumura T., Kondo T., Taguchi T., Nakamaru K., Yano M., Kukidome D., Matsumoto K., Toyonaga T., Asano T., Nishikawa T., Araki E. AMPK suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ. Res. 2005; 97: 837–844
   PubMed Web of Science ®Google Scholar
• Sasaki T., Hohenester E., Gohring W., Timpl R. Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin. EMBO J. 1998; 17: 1625–1634
   PubMed Web of Science ®Google Scholar
• Raynal N., Hamaia S. W., Siljander P. R., Madox B., Peachey A. R., Fernandez R., Foley L. J., Slater D. A., Jarvis G. E., Farndale R. W. Use of synthetic peptides to locate novel integrin α2β1-binding motifs in human collagen III. J. Biol. Chem. 2006; 281: 3821–3831
   PubMed Web of Science ®Google Scholar
• Farndale R. W., Lisman T., Bihan D., Hamaia S., Smerling C. S., Ough N., Konitsiotis A., Leitinger B., deGroot P. G., Jarvis G. E., Raynal N. Cell—collagen interactions: the use of peptide Toolkits to investigate collagen—receptor interactions. Biochem. Soc. Trans. 2008; 36: 241–250
   PubMed Web of Science ®Google Scholar
• Guermah M., Crisanti P., Laugier D., Dezelee P., Bidou L., Pessac B., Calothy G. Transcription of a quail gene expressed in embryonic retinal cells is shut off sharply at hatching. Proc. Natl. Acad. Sci. USA 1991; 88: 4503–4507
   PubMed Web of Science ®Google Scholar
• Girard J.-P., Springer T. A. Cloning from purified high endothelial venule cells of hevin, a close relative of the antiadhesive extracellular matrix protein SPARC. Immunity 1995; 2: 113–123
   PubMed Web of Science ®Google Scholar